The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application (TM99341594) for the mark 'HEMOLUME'. The application specifies the goods as medical devices, including radiation devices such as ultraviolet, visible, or infra-red light boxes intended for counteracting viruses, bacteria, and pathogens in blood and blood components. The filing date for this application was August 17, 2025, with an intent-to-use date set for March 24, 2026.

This filing represents a new trademark application for a medical device. While not a regulatory rule or guidance, it indicates a potential new market entrant or product line in the medical device sector. Compliance officers in the medical device industry should note this application as it pertains to a specific type of medical radiation device. No immediate compliance actions are required based solely on this trademark filing, but it may signal future product launches or market activities.